Clement Goehrs

Co-Founder & CEO, Synapse Medicine - Medication Intelligence
New York, New York,United States
Find Clement Goehrs's Email
Find Clement Goehrs's Phone

Who Is Clement Goehrs?

Total Experience14 years
CompanySynapse Medicine - Medication Intelligence
CountryUnited States

Clement Goehrs is a medical doctor and entrepreneur, best known as the co-founder and CEO of Synapse Medicine. With a background in public health and clinical pharmacology, Dr. Goehrs identified a critical need for reliable and easily accessible medication information for both healthcare professionals and patients. This led him to establish Synapse Medicine in 2017, a company dedicated to leveraging artificial intelligence to provide trustworthy drug intelligence, aiming to prevent medication errors, improve prescription accuracy, and enhance patient safety. He is passionate about transforming healthcare through technology and is a recognized voice in the health-tech industry, advocating for data-driven solutions to complex medical challenges.

How Did Clement Goehrs's Career Path Shape Their Journey?

Clement Goehrs's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Synapse Medicine - Medication Intelligence - Co-Founder & CEO(2017 to Present)
Stanford University - Visiting Research Scholar(2016 to 2017)
Hacking Health - Leader & Co-Founder - Hacking Health Bdx, Non-Profit Organization(2015 to 2017)
Bordeaux University Hospital / INSERM 1219 Computer research applied to health – ERIAS Team - Resident Medical Officer(2015 to 2016)
Bordeaux University Hospital - Methodological Support Unit in Clinical Research (USMR) - Medical Resident(2015 to 2015)
Bordeaux University Hospital - Coordination & Medical Information Analysis Unit - Medical Resident(2014 to 2015)
Association of Public Health Resident Bordeaux - AISPB - President(2014 to 2015)
INSERM - Medical Resident(2014 to 2014)
Inserm - Medical Resident(2013 to 2014)

What Are Clement Goehrs's Key Achievements?

Co-founder and CEO of Synapse Medicine

Successfully co-founded Synapse Medicine in 2017 and has since led its growth as CEO, establishing it as a leading platform for AI-powered medication intelligence used by thousands of healthcare professionals and major healthcare organizations.

Securing Significant Funding for Health Tech Innovation

Spearheaded multiple successful funding rounds for Synapse Medicine, including a notable $28 million Series B in 2021, enabling the company to scale its operations, expand its team, and further develop its AI capabilities for global impact.

Advancing Medication Safety through AI

Pioneered the application of artificial intelligence to create a reliable and up-to-date medication information system, directly contributing to the reduction of medication errors and improving patient outcomes in clinical practice.

Recognition in Health Tech Leadership

Gained recognition as an influential leader in the European health tech scene, often invited to speak at industry conferences and contributing to discussions on the future of digital health and AI in medicine.

What's Clement Goehrs's Educational Background?

General Management : LEAD program for Corporate Innovation

Stanford University Graduate School of Business - Year 2016

Master's degree, Biomedical Informatics

Institut de santé publique, d'épidémiologie et de développement (ISPED) - Year 2015

Master of Public Health - MPH ( French DESC of Public Health ), Public Health

Université de Bordeaux - Year 2013

Doctor of Medicine (M.D.)

Université Paris-Saclay - Year 2006

Baccalauréat, Scientifique

Lycée Hoche

Buying Intent Signals for Clement Goehrs

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Synapse Medicine - Medication Intelligence
Total employees180
HeadquartersBordeaux
Founded2017

Synapse Medicine is a Medication Intelligence company dedicated to ensuring everyone has access to reliable and up-to-date drug information. Their AI-powered platform helps healthcare professionals make informed decisions about prescriptions, reducing medication errors and improving patient safety. For patients, it offers tools to better understand their treatments and manage their health.

Synapse Medicine - Medication Intelligence Funding Information
Unknown - Total Funding Raised
$28M - Most recent funding amount
3 - Number of funding rounds
Sep 21, 2021 - Latest funding round
Lead Investors:
MACSF
XAnge
Bpifrance
Kreaxi
BNP Paribas Development
Nicolas Dessaigne
Jean-Marc Ogier

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.